Have a personal or library account? Click to login
Coronary artery events in Thai patients with psoriasis using Framingham and Ramathibodi–Electricity Generating Authority of Thailand risk scores Cover

Coronary artery events in Thai patients with psoriasis using Framingham and Ramathibodi–Electricity Generating Authority of Thailand risk scores

Open Access
|Jan 2017

References

  1. 1Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97:1837-47.960353910.1161/01.CIR.97.18.1837
    WilsonPWD’AgostinoRBLevyDBelangerAMSilbershatzHKannelWBPrediction of coronary heart disease using risk factor categoriesCirculation1998971837479603539
  2. 2Asia Pacific Cohort Studies Collaboration, Brazil F, Patel A, Gu D, Sritara P, Lam TH, et al. Cardiovascular risk prediction tools for populations in Asia. J Epidemiol Community Health. 2007; 61:115-21.1723486910.1136/jech.2005.044842
    AsiaPacific Cohort Studies CollaborationBrazilFPatelAGuD itara PSrLamTHet alCardiovascular risk prediction tools for populations in AsiaJ Epidemiol Community Health20076111521246563817234869
  3. 3Sritara P, Cheepudomwit S, Chapman N, Woodward M, Kositchaiwat C, Tunlayadechanont S, et al. Twelve-year changes in vascular risk factors and their associations with mortality in a cohort of 3499 Thais: the Electricity Generating Authority of Thailand Study. Int J Epidemiol. 2003; 32:461-8.10.1093/ije/dyg105
    SritaraPCheepudomwitSChapmanNWoodwardMKositchaiwatCTunlayadechanontSet alTwelve-year changes in vascular risk factors and their associations with mortality in a cohort of 3499 Thais: the Electricity Generating Authority of Thailand StudyInt J Epidemiol200332461812777437
  4. 4Pattanaprichakul S, Jongjirasiri S, Yamwong S. RAMA-EGAT risk score for predicting coronary artery disease evaluated by 64-slice angiography. Asean Heart J. 2007; 15:18-22.
    PattanaprichakulSJongjirasiriSYamwongSRAMA-EGAT risk score for predicting coronary artery disease evaluated by 64-slice angiographyAsean Heart J2007151822
  5. 5Hugh J, Van Voorhees AS, Nijhawan RI, Bagel J, Lebwohl M, Blauvelt A, et al. From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies. J Am Acad Dermatol. 2014; 70:168-77.10.1016/j.jaad.2013.09.020
    HughJVanVoorhees ASNijhawanRIBagelJLebwohlMBlauveltAet alFrom the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapiesJ Am Acad Dermatol2014701687724184141
  6. 6Deurenberg P, Deurenberg-Yap M, Guricci S. Asians are different from Caucasians and from each other in their body mass index body fat per cent relationship. Obes Rev. 2002; 3:141-6.1216446510.1046/j.1467-789X.2002.00065.x
    DeurenbergPDeurenberg-YapMGuricciSAsians are different from Caucasians and from each other in their body mass index body fat per cent relationshipObes Rev20023141612164465
  7. 7D’Agostino RB Sr, Grundy S, Sullivan LM, Wilson P. CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001; 286:180-7.10.1001/jama.286.2.18011448281
    D’AgostinoRBSrGrundySSullivanLMWilsonPCHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigationJAMA2001286180711448281
  8. 8Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001; 285:2486-97.
    Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)JAMA200128524869710.1001/jama.285.19.248611368702
  9. 9Mehta NN, Yu Y, Pinnelas R, Krishnamoorthy P, Shin DB, Troxel AB, et al. Attributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med. 2011; 124:775.21787906
    MehtaNNYuYPinnelasRKrishnamoorthyPShinDBTroxelABet alAttributable risk estimate of severe psoriasis on major cardiovascular eventsAm J Med201112477510.1016/j.amjmed.2011.03.028314603721787906
  10. 10Aekplakorn W, Kosulwat V, Suriyawongpaisal P. Obesity indices and cardiovascular risk factors in Thai adults. Int J Obes (Lond). 2006; 30:1782-90.1661905510.1038/sj.ijo.0803346
    AekplakornWKosulwatVSuriyawongpaisalPObesity indices and cardiovascular risk factors in Thai adultsInt J Obes (Lond)20063017829016619055
  11. 11Aekplakorn W, Kessomboon P, Sangthong R, Chariyalertsak S, Putwatana P, Inthawong R, et al. Urban and rural variation in clustering of metabolic syndrome components in the Thai population: results from the fourth National Health Examination Survey 2009. BMC Pub Health. 2011; 11:854-62.10.1186/1471-2458-11-854
    AekplakornWKessomboonPSangthongRChariyalertsakSPutwatanaPInthawongRet alUrban and rural variation in clustering of metabolic syndrome components in the Thai population: results from the fourth National Health Examination Survey 2009BMC Pub Health20111185462328271622074341
  12. 12Edward-Jackson N, Kerr S, Tieu H, Ananworanich J, Hammer S, Ruxrungtham K, et al. Cardiovascular risk assessment in persons with HIV infection in the developing world: comparing three risk equations in a cohort of HIV-infected Thais. HIV Med. 2011; 12: 510-5.10.1111/j.1468-1293.2011.00916.x
    Edward-JacksonNKerrSTieuHAnanworanichJHammerSRuxrungthamKet alCardiovascular risk assessment in persons with HIV infection in the developing world: comparing three risk equations in a cohort of HIV-infected ThaisHIV Med201112510521375686
  13. 13Friis-Moller N, Thiebaut R, Reiss P, Weber R, Monforte AD, De Wit S, et al. Predicting the risk of cardiovascular disease in HIV-infected patients; the data collection on adverse effects of anti-HIV drugs (D:A:D) study. Eur J Cardiovasc Prev Rehabil. 2010; 17:491-501.10.1097/HJR.0b013e328336a150
    Friis-MollerNThiebautRReissPWeberRMonforteADDeWit Set alPredicting the risk of cardiovascular disease in HIV-infected patients; the data collection on adverse effects of anti-HIV drugs (D:A:D) studyEur J Cardiovasc Prev Rehabil20101749150120543702
  14. 14Choi WJ, Park EJ, Kwon IH, Kim KH, Kim KJ. Association between psoriasis and cardiovascular risk factors in Korean patients. Ann Dermatol. 2010; 22:300-6.2071126610.5021/ad.2010.22.3.300
    ChoiWJParkEJKwonIHKimKHKimKJAssociation between psoriasis and cardiovascular risk factors in Korean patientsAnn Dermatol2010223006291768320711266
  15. 15Fernandez-Torres R, Pita-Fernandez S, Fonseca E. Psoriasis and cardiovascular risk. Assessment by different cardiovascular risk scores. J Eur Acad Dermatol Venereol. 2013; 27:1566-70.10.1111/j.1468-3083.2012.04618.x22731956
    Fernandez-TorresRPita-FernandezSFonsecaEPsoriasis and cardiovascular risk. Assessment by different cardiovascular risk scoresJ Eur Acad Dermatol Venereol20132715667022731956
  16. 16Rosa DJ, Machado RF, Matias FA, Cedrim SD, Noronha FL, Gaburri D, et al. Influence of severity of the cutaneous manifestations and age on the prevalence of several cardiovascular risk factors in patients with psoriasis. J Eur Acad Dermatol Venereol. 2012; 26:348-53.10.1111/j.1468-3083.2011.04076.x21545540
    RosaDJMachadoRFMatiasFACedrimSDNoronhaFLGaburriDet alInfluence of severity of the cutaneous manifestations and age on the prevalence of several cardiovascular risk factors in patients with psoriasisJ Eur Acad Dermatol Venereol2012263485321545540
  17. 17Kimball AB, Szapary P, Mrowietz U, Reich K, Lanfley RG, You Y, et al. Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis. J Am Acad Dermatol. 2012; 67: 76-85.2201875610.1016/j.jaad.2011.06.035
    KimballABSzaparyPMrowietzUReichKLanfleyRGYouYet alUnderdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasisJ Am Acad Dermatol201267768522018756
  18. 18Mehta NN, Krishnamoorthy P, Yu Y, Khan O, Raper A, Van Voorhees A, et al. The impact of psoriasis on 10-year Framingham risk. J Am Acad Dermatol. 2012; 67:796-8.10.1016/j.jaad.2012.05.01622739354
    MehtaNNKrishnamoorthyPYuYKhanORaperAVanVoorhees Aet alThe impact of psoriasis on 10-year Framingham riskJ Am Acad Dermatol2012677968344467322739354
  19. 19Torres T, Sales R, Vasconcelos C, Martins da Silva B, Selores M. Framingham risk score underestimates cardiovascular disease risk in severe psoriatic patients: implications in cardiovascular risk factors management and primary prevention of cardiovascular disease. J Dermatol. 2013; 40:923-6.10.1111/1346-8138.1226724128349
    TorresTSalesRVasconcelosCMartinsda Silva BSeloresMFramingham risk score underestimates cardiovascular disease risk in severe psoriatic patients: implications in cardiovascular risk factors management and primary prevention of cardiovascular diseaseJ Dermatol201340923624128349
DOI: https://doi.org/10.5372/1905-7415.0904.419 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Language: English
Page range: 495 - 500
Published on: Jan 31, 2017
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2017 Sakunee Khankham, Leena Chularojanamontri, Chanisada Wongpraparut, Narumol Silpa-archa, Nuttaporn Janyong, Prin Vathesatogkit, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.